Detailseite
Projekt Druckansicht

A synthetic lethal screen to identify novel targets for therapy in acute myeloid leukemia

Fachliche Zuordnung Hämatologie, Onkologie
Förderung Förderung von 2008 bis 2015
Projektkennung Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 59021035
 
Erstellungsjahr 2017

Zusammenfassung der Projektergebnisse

The data provide strong evidence that cancer cells survive ara-C induced DNA-damage by increasing translesional DNA-synthesis. Depletion of genes that code for important proteins responsible for translesional DNA-synthesis re-sensitizes cancer cells towards ara-C. The data generated within the KFO210 thus may result in novel therapeutic approaches by targeting these genes or involved processes in the future. A first step in this direction may be the combined usage of a Neddylation inhibitor targeting the cullin-RING family of E3 ligases together with ara-C. And indeed, recently first clinical data have shown a synergistic effect.

Projektbezogene Publikationen (Auswahl)

 
 

Zusatzinformationen

Textvergrößerung und Kontrastanpassung